Tag:#Kanabo Group

From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity

As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US. AFTER picking up their script from a...

Kanabo Aiming To Become Europe’s First Cannabis ‘Unicorn’

UK Market-listed cannabis business Kanabo is now generating its first revenues following the successful launch of its flagship VapePod product.  The medical cannabis vapes were...

Conservative MP Dr Dan Poulter Joins UK Cannabis Company’s Board Of Directors

MEDICAL cannabis company Kanabo Group has appointed Dr Dan Poulter MP as a Non-Executive Director to the board. Dr Poulter, a former UK Government health...

Kanabo Group Joins LSE With ’50 More Cannabis Companies’ Set To Follow

MEDICAL cannabis device maker Kanabo Group will today become the second cannabis company to list on the London Stock Exchange. CEO Avihu Tamir believes it...

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...
- Advertisement -spot_imgspot_img

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Must read